TITLE

Il tromboembolismo venoso in chirurgia urologica: fattori di rischio e strategie di tromboprofilassi

AUTHOR(S)
FOSCHL, N.; GULINO, G.; RACIOPPL, M.; TOTARO, A.; CELLA, G.; BASSI, PF.
PUB. DATE
December 2009
SOURCE
Urologia;2009 Supplement, Vol. 76 Issue S-12, pS22
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Surgery and especially cancer surgery is recognised as a risk condition for the development of venous trhomboembolism (VTE), deep venous thrombosis (DVT) and pulmonary embolism (PE). VTE is considered the most important non surgical complication of major urological procedures. Epidemiological data are based on studies published 10-30 years ago and mostly based on venographic diagnosis of DVT. Clinical revelance of asymptomatic detected DVT is under debate. The rationale for thromboprophylaxis is based on the high prevalence of VTE among hospitalized patients, the clinically silent nature of the disease in the majority of patients, and the morbidity, costs, and potential mortality associated with unprevented thrombi. Both DVT and PE produce few specific symptoms, and the clinical diagnosis is unreliable. Since the first manifestation of the disease may be fatal PE, it is inappropriate to wait for symptoms and then rely on the diagnosis and treatment of established VTE. The thromboprophylaxis strategies are still debated with regards to therapeutical choices (pharmacological and/or mechanic prophylaxis) and modalities. The strategy to be applied in patients chronically under anticoagulant or antiplatelet drugs (TAO) is also a controversial issue. METHODS: Literature review on VTE and antithrombotic prophylaxis in urological cancer surgery. RESULTS: Although the incidence of VTE is lower in urological patients than that in the others, thromboprophylaxis is still a debated topic for urologists. A protective role is the shorter duration of a lot of endourological procedure and the reduced need of general anesthesia. Nowadays patients are elderly and have multiple risk factors so they have to receive a valid and safe thromboprophylaxis. Even if the risk of bleeding is bigger in patients who received antithrombotic pro philaxys this do not allow to ignore the bigger risk/benefits ratio of the antithrombotic therapies. CONCLUSIONS: VTE is a serious complication of the urologic cancer surgery and remains the most common cause of death in these patients. New efforts must be done to reduce the risk ant to optimize the prophylapctic strategies particularly in patients with known risk factors.
ACCESSION #
41334833

 

Related Articles

  • Preventing deep vein thrombosis in hospital inpatients. Cayley, William E. // BMJ: British Medical Journal (International Edition);7/21/2007, Vol. 335 Issue 7611, p147 

    This article discusses the risk factors for deep vein thrombosis (DVT) with hospital inpatients including triad stasis, vessel injury and hypercoagulability, especially in patients undergoing hip or knee surgery or following major trauma. Preventative measures are encouraged as DVT can occur...

  • Venous thromboembolism. Blann, Andrew D.; Li, Gregory Y.H. // BMJ: British Medical Journal (International Edition);1/28/2006, Vol. 332 Issue 7535, p215 

    The article presents a clinical review of the risks, onset, pathology, prevention and treatment of venous thromboembolism. The condition, comprising both deep vein thrombosis and pulmonary embolism, are commonly seen in hospitals. Risk factors include age, cancer, thrombophilia, and recent...

  • Risk Factors for Venous Thromboembolism and Duration of Anticoagulation Therapy. Antonijević, Nebojša M.; Kanjuh, Vladimir; Živković, Ivana; Jovanović, Ljubica // Scripta Medica;May2013, Vol. 44 Issue 1, p35 

    An adequate regimen for prophylaxis of venous thromboembolism (VTE) requires indentification of reversible and irreversible risk factors. Recent data confirm that the greatest number of pulmonary emboli (PE) occur in non-surgical patients. VTE also develops in many surgical patients upon...

  • Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Moores, Lisa K.; Jackson, Jr., William L.; Shorr, Andrew F.; Jackson, Jeffrey L.; Jackson, William L Jr // Annals of Internal Medicine;12/7/2004, Vol. 141 Issue 11, p866 

    Background: Spiral computed tomographic pulmonary angiography (CTPA) is increasingly being used in the evaluation of patients with clinically suspected pulmonary embolism (PE). However, CTPA as a definitive diagnostic test may be limited by inadequate sensitivity, especially in...

  • Clinical overview of venous thromboembolism. Schellack, Gustav; Modau, Tumelo; Schellack, Natalie // South African Pharmaceutical Journal;2015, Vol. 82 Issue 10, p21 

    Venous thromboembolism (VTE) encompasses two vascular conditions that are of significant importance, namely deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is also the most common cause of PE. Medical and surgical patients, and individuals who are at increased risk of developing VTE...

  • The Prevention of Venous Thromboembolism in Older Adults: Guidelines. Aronow, Wilbert S. // Journals of Gerontology Series A: Biological Sciences & Medical ;Jan2004, Vol. 59 Issue 1, p42 

    The rationale for thromboprophylaxis is based on the high prevalence of venous thromboembolism (VTE), a disorder involving deep vein thrombosis (DVT) and pulmonary embolism (PE), among hospitalized patients, the clinically silent nature of VTE in most patients, and the morbidity, cost, and...

  • Pharmacists can help prevent venous thromboembolism. LoBuono, Charlotte // Drug Topics;9/15/2003, Vol. 147 Issue 18, p8 

    Highlights a report concerning deep vein thrombosis (DVT) and pulmonary embolism (PE) in the United States. Underutilization of regimens for the prevention of venous thromboembolism (VTE); Progress in clinical trials and guidelines for the prophylaxis and treatment of VTE; Difficulties in...

  • Nouveaux anticoagulants. Mise au point et enjeux en chirurgie orale. Lansonneur, C�dric; Guillou, Pauline; Hacquard, Aur�lie; Devisse, Manon; Lelievre, Julie; Le Gal, Gr�goire; Boisram�-Gastrin, Sylvie // M�decine Buccale Chirurgie Buccale;2013, Vol. 19 Issue 1, p11 

    Heparins, either unfractionated or lowmolecular- weight (UFH and LMWHs), and vitamin K antagonists (VKA) are currently the anticoagulants of choice for the prevention of postoperative venous thromboembolism (VTE) and for the treatment of acute venous and arterial thromboembolism. Heparins are...

  • Comparison of Oral Anticoagulants and Low Molecular Weight Heparins (LMWH) on Outcome of Patients with Deep Vein Thrombosis (DVT). Syed, MujtabaHussain Naqvi; Ramakrishna, Pinjala; Mahapatra, Sandeep // World Applied Sciences Journal;2014, Vol. 31 Issue 5, p954 

    Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT), is a potentially fatal disease. The outcome of treatment with initial LMWH followed by either oral anticoagulants or prophylactic LMWH for 4 months in Indian patients is lacking. The case records of patients with infra...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics